QIAGEN N.V. (QGEN) Dividend History

Company News

• Oncology Molecular Diagnostics Market Size Drives USD 9.76 Billion by 2034

  The global oncology molecular diagnostics market is expected to grow from $3.48 billion in 2025 to $9.76 billion by 2034, with a 12.13% CAGR. North America currently dominates the market, with breast cancer diagnostics leading market segments and technological innovations driving growth.

  GlobeNewswire Inc.

  Featured Companies: ABT DHR TMO
• Sample Preparation Market is Poised to Register CAGR of 6.4% by 2031 | SkyQuest Technology

  The global sample preparation market is expected to grow at a CAGR of 6.4% by 2031, driven by technological advancements in specimen collection and preparation. The consumables segment and solid-phase extraction technique are expected to lead the market growth.

  Benzinga

  Featured Companies: A BIO BIO.B BRKR DHR GEHC MTD PKI TMO
• Pre Q3 Earnings: Is Hologic (HOLX) Stock a Portfolio Must-Have? - Zacks Investment Research

  Hologic, a women's health-focused diagnostics company, is set to report its fiscal 2024 third-quarter results. The performance is expected to reflect the strength of the company's core franchises, overcoming the challenging comparisons of fiscal 2023. The company's broad menu of molecular diagnostics tests, excluding COVID-19 assays, and strong performance in its Breast Health and GYN Surgical segments are likely to drive growth.

  Zacks Investment Research

  Featured Companies: ABT HOLX
• Wall Street Breakfast: The Week Ahead

  Stay updated on Wall Street news with our daily podcast available on Seeking Alpha, iTunes, and Spotify.

  Seeking Alpha

  Featured Companies: ACN ADMA BFH CBUS CRMT DRI EBAY FDS GME IREN KBH KMX KR KROS LEN LZB MAXN MDB NNE NVRI ORA PAL PATH PSTG SVCO TRUP WMT